Download Files:
Teriflunomide
SKU
HY-15405-10 mg
Category Reference compound
Tags Drug Metabolite, Inflammation/Immunology, Metabolic Enzyme/Protease
$35 – $198
Products Details
Product Description
– Teriflunomide is the active metabolite of leflunomide, an approved therapy for rheumatoid arthritis. It inhibits pyrimidine synthesis and therefore potently decreases T cell and B cell proliferation.
Web ID
– HY-15405
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C12H9F3N2O2
References
– [1]Oh J, et al. An update of teriflunomide for treatment of multiple sclerosis. Ther Clin Risk Manag. 2013;9:177-90.
CAS Number
– 163451-81-8
Molecular Weight
– 270.21
Compound Purity
– 99.94
SMILES
– C/C(O)=C(C#N)/C(NC1=CC=C(C(F)(F)F)C=C1)=O
Clinical Information
– Launched
Research Area
– Inflammation/Immunology
Solubility
– DMSO : 33.33 mg/mL (ultrasonic)
Target
– Drug Metabolite
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.